Top

The International Journal of Cardiovascular Imaging

Published in:

Open Access 01-02-2010 | Editorial Comment

Tissue characterization in Takotsubo cardiomyopathy; a valuable approach?

Author: E. E. van der Wall

Published in: The International Journal of Cardiovascular Imaging | Issue 2/2010

Excerpt

Over the past years considerable progress has been made in the field of CMR, which provides accurate evaluation of left ventricular function particularly in patients with ischemic heart disease and various manifestations of cardiomyopathy [1‐11]. Stress first-pass contrast-enhanced myocardial perfusion CMR can be used to detect subendocardial ischemia and recent studies have demonstrated the high diagnostic accuracy of stress myocardial perfusion CMR for detecting significant coronary artery disease [12‐17]. Magnetic resonance angiography (MRA) has been introduced as a method that can provide visualization of all three major coronary arteries, coronary anomalies, coronary bypasses and the aorta within a single three-dimensional acquisition [18‐21]. CMR has become the first choice imaging modality in complex congenital heart disease [22‐26] and imaging great vessels [27‐30]. …

van der Wall EE, Vliegen HW, de Roos A, Bruschke AV (1995) Magnetic resonance imaging in coronary artery disease. Circulation 92:2723–2739PubMed

Bavelaar-Croon CD, Kayser HW, van der Wall EE et al (2000) Left ventricular function: correlation of quantitative gated SPECT and MR imaging over a wide range of values. Radiology 217:572–575PubMed

Bax JJ, Lamb H, Dibbets P et al (2000) Comparison of gated single-photon emission computed tomography with magnetic resonance imaging for evaluation of left ventricular function in ischemic cardiomyopathy. Am J Cardiol 86:1299–1305CrossRefPubMed

Posma JL, Blanksma PK, van der Wall EE, Hamer HP, Mooyaart EL, Lie KI (1996) Assessment of quantitative hypertrophy scores in hypertrophic cardiomyopathy: magnetic resonance imaging versus echocardiography. Am Heart J 132:1020–1027CrossRefPubMed

Pluim BM, Beyerbacht HP, Chin JC et al (1997) Comparison of echocardiography with magnetic resonance imaging in the assessment of the athlete’s heart. Eur Heart J 18:1505–1513PubMed

Pluim BM, Chin JC, De Roos A et al (1996) Cardiac anatomy, function and metabolism in elite cyclists assessed by magnetic resonance imaging and spectroscopy. Eur Heart J 17:1271–1278PubMed

van der Wall EE, den Hollander W, Heidendal GA, Westera G, Majid PA, Roos JP (1981) Dynamic myocardial scintigraphy with 123I-labeled free fatty acids in patients with myocardial infarction. Eur J Nucl Med 6:383–389PubMed

Braun S, van der Wall EE, Emanuelsson S, Kobrin I (1996) Effects of a new calcium antagonist, mibefradil (Ro 40–5967), on silent ischemia in patients with stable chronic angina pectoris: a multicenter placebo-controlled study. The mibefradil international study group. J Am Coll Cardiol 27:317–322CrossRefPubMed

Holman ER, Buller VG, de Roos A et al (1997) Detection and quantification of dysfunctional myocardium by magnetic resonance imaging. A new three-dimensional method for quantitative wall-thickening analysis. Circulation 95:924–931PubMed

10.

Schuijf JD, Bax JJ, Shaw LJ et al (2006) Meta-analysis of comparative diagnostic performance of magnetic resonance imaging and multislice computed tomography for noninvasive coronary angiography. Am Heart J 151:404–411CrossRefPubMed

11.

Ypenburg C, van der Wall EE, Schalij MJ, Bax JJ (2008) Imaging in cardiac resynchronisation therapy. Neth Heart J 16:S36–S40PubMed

12.

van Rugge FP, van der Wall EE, Bruschke AV (1992) New developments in pharmacologic stress imaging. Am Heart J 124:468–485CrossRefPubMed

13.

van Rugge FP, Holman ER, van der Wall EE et al (1993) Quantitation of global and regional left ventricular function by cine magnetic resonance imaging during dobutamine stress in normal human subjects. Eur Heart J 14:456–463PubMed

14.

Pluim BM, Lamb HJ, Kayser HW, Leujes F et al (1998) Functional and metabolic evaluation of the athlete’s heart by magnetic resonance imaging and dobutamine stress magnetic resonance spectroscopy. Circulation 97:666–672PubMed

15.

van Rugge FP, van der Wall EE, Spanjersberg SJ et al (1994) Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method. Circulation 90:127–138PubMed

16.

Nemes A, Geleijnse ML, van Geuns RJ et al (2008) Dobutamine stress MRI versus threedimensional contrast echocardiography: it’s all black and white. Neth Heart J 16:217–218PubMed

17.

Bleeker GB, Bax JJ, Fung JW et al (2006) Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. Am J Cardiol 97:260–263CrossRefPubMed

18.

Schuijf JD, Bax JJ, van der Wall EE (2007) Anatomical and functional imaging techniques: basically similar or fundamentally different? Neth Heart J 15:43–44PubMed

19.

Vliegen HW, Doornbos J, de Roos A, Jukema JW, Bekedam MA, van der Wall EE (1997) Value of fast gradient echo magnetic resonance angiography as an adjunct to coronary arteriography in detecting and confirming the course of clinically significant coronary artery anomalies. Am J Cardiol 79:773–776CrossRefPubMed

20.

Hoogendoorn LI, Pattynama PM, Buis B, van der Geest RJ, van der Wall EE, de Roos A (1995) Noninvasive evaluation of aortocoronary bypass grafts with magnetic resonance flow mapping. Am J Cardiol 75:845–848CrossRefPubMed

21.

Langerak SE, Vliegen HW, de Roos A et al (2002) Detection of vein graft disease using high-resolution magnetic resonance angiography. Circulation 105:328–333CrossRefPubMed

22.

Rebergen SA, Ottenkamp J, Doornbos J, van der Wall EE, Chin JG, de Roos A (1993) Postoperative pulmonary flow dynamics after Fontan surgery: assessment with nuclear magnetic resonance velocity mapping. J Am Coll Cardiol 21:123–131PubMedCrossRef

23.

Groenink M, Lohuis TA, Tijssen JG et al (1999) Survival and complication free survival in Marfan’s syndrome: implications of current guidelines. Heart 82:499–504PubMed

24.

Tulevski II, Hirsch A, Sanson BJ et al (2001) Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism. Thromb Haemost 86:1193–1196PubMed

25.

Niezen RA, Helbing WA, van der Wall EE, van der Geest RJ, Rebergen SA, de Roos A (1996) Biventricular systolic function and mass studied with MR imaging in children with pulmonary regurgitation after repair for tetralogy of Fallot. Radiology 201:135–140PubMed

26.

Vliegen HW, van Straten A, de Roos A et al (2002) Magnetic resonance imaging to assess the hemodynamic effects of pulmonary valve replacement in adults late after repair of tetralogy of Fallot. Circulation 106:1703–1707CrossRefPubMed

27.

Oosterhof T, van Straten A, Vliegen HW et al (2007) Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 116:545–551CrossRefPubMed

28.

van der Geest RJ, de Roos A, van der Wall EE, Reiber JH (1997) Quantitative analysis of cardiovascular MR images. Int J Card Imaging 13:247–258CrossRefPubMed

29.

van der Geest RJ, Niezen RA, van der Wall EE, de Roos A, Reiber JH (1998) Automated measurement of volume flow in the ascending aorta using MR velocity maps: evaluation of inter- and intraobserver variability in healthy volunteers. J Comput Assist Tomogr 22:904–911CrossRefPubMed

30.

van der Laarse A, Kerkhof PL, Vermeer F et al (1988) Relation between infarct size and left ventricular performance assessed in patients with first acute myocardial infarction randomized to intracoronary thrombolytic therapy or to conventional treatment. Am J Cardiol 61:1–7CrossRefPubMed

31.

de Roos A, Matheijssen NA, Doornbos J et al (1990) Myocardial infarct size after reperfusion therapy: assessment with Gd-DTPA-enhanced MR imaging. Radiology 176:517–521PubMed

32.

de Roos A, Matheijssen NA, Doornbos J, van Dijkman PR, van Rugge PR, van der Wall EE (1991) Myocardial infarct sizing and assessment of reperfusion by magnetic resonance imaging: a review. Int J Card Imaging 7:133–138CrossRefPubMed

33.

van Rugge FP, Boreel JJ, van der Wall EE et al (1991) Cardiac first-pass and myocardial perfusion in normal subjects assessed by sub-second Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 15:959–965PubMed

34.

van Rugge FP, van der Wall EE, van Dijkman PR, Louwerenburg HW, de Roos A, Bruschke AV (1992) Usefulness of ultrafast magnetic resonance imaging in healed myocardial infarction. Am J Cardiol 70:1233–1237CrossRefPubMed

35.

Holman ER, van Jonbergen HP, van Dijkman PR, van der Laarse A, de Roos A, van der Wall EE (1993) Comparison of magnetic resonance imaging studies with enzymatic indexes of myocardial necrosis for quantification of myocardial infarct size. Am J Cardiol 71:1036–1040CrossRefPubMed

36.

Buller VG, van der Geest RJ, Kool MD, van der Wall EE, de Roos A, Reiber JH (1997) Assessment of regional left ventricular wall parameters from short axis magnetic resonance imaging using a three-dimensional extension to the improved centerline method. Invest Radiol 32:529–539CrossRefPubMed

37.

Holman ER, van Rossum AC, Doesburg T, van der Wall EE, de Roos A, Visser CA (1996) Assessment of acute myocardial infarction in man with magnetic resonance imaging and the use of a new paramagnetic contrast agent gadolinium-BOPTA. Magn Reson Imaging 14:21–29CrossRefPubMed

38.

Krauss XH, Van der Wall EE, Doornbos J et al (1989) Value of magnetic resonance imaging in patients with a recent myocardial infarction: comparison with planar thallium-201 scintigraphy. Cardiovasc Intervent Radiol 12:119–124CrossRefPubMed

39.

van der Wall EE, Bax JJ (2008) Late contrast enhancement by CMR: more than scar? Int J Cardiovasc Imaging 24:609–611CrossRefPubMed

40.

Nijveldt R, Beek AM, Hirsch A et al (2008) ‘No-reflow’ after acute myocardial infarction: direct visualisation of microvascular obstruction by gadolinium-enhanced CMR. Neth Heart J 16:179–181PubMed

41.

van der Hoeven BL, Pires NM, Warda HM et al (2005) Drug-eluting stents: results, promises and problems. Int J Cardiol 99:9–17CrossRefPubMed

42.

van der Laan A, Hirsch A, Nijveldt R et al (2008) Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results. Neth Heart J 16:436–439PubMed

43.

Higgins CB, Herfkens R, Lipton MJ et al (1983) Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: Alterations in magnetic resonance times. Am J Cardiol 52:184–188CrossRefPubMed

44.

Matheijssen NA, de Roos A, van der Wall EE et al (1991) Acute myocardial infarction: comparison of T2-weighted and T1-weighted gadolinium-DTPA enhanced MR imaging. Magn Reson Med 17:460–469CrossRefPubMed

45.

Krauss XH, van der Wall EE, van der Laarse A et al (1990) Follow-up of regional myocardial T2 relaxation times in patients with myocardial infarction evaluated with magnetic resonance imaging. Eur J Radiol 11:110–119CrossRefPubMed

46.

Choi SH, Kang J-W, Kim S-T et al (2009) Investigation of T2-weighted signal intensity of infarcted myocardium and its correlation with delayed enhancement magnetic resonance imaging in a porcine model with reperfused acute myocardial infarction. Int J Cardiovasc Imaging 25(Suppl 1):111–119CrossRefPubMed

47.

Abdel-Aty H, Zagrosek A, Schulze-Menger J et al (2004) Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 109:2411–2416CrossRefPubMed

48.

Aletras AH, Tilak GS, Natanzon A et al (2006) Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging. Circulation 113:1865–1870CrossRefPubMed

49.

Stork A, Lund GK, Muellerleile K et al (2006) Characterization of the peri-infarction zone using T2-weighted MRI and delayed-enhancement MRI in patients with acute myocardial infarction. Eur Radiol 16:2350–2357CrossRefPubMed

50.

Joshi SB, Chow T, Herzka DA et al. (2009). Cardiovascular magnetic resonance T2 signal abnormalities in left ventricular ballooning syndrome. Int J Cardiovasc Imaging (Epub ahead of print)

51.

Scholte AJ, Bax JJ, Stokkel MP et al (2006) Multimodality imaging to diagnose takotsubo cardiomyopathy. J Nucl Cardiol 13:123–126CrossRefPubMed

52.

Alizadeh Dehnavi R, van der Wall EE (2005) Transient left ventricular apical ballooning. Ann Intern Med 142:678PubMed

53.

Alizadeh Dehnavi R, van der Wall EE, Smits PC (2006) Left ventricular apical ballooning. Int J Cardiovasc Imaging 22:327–331CrossRefPubMed

54.

Gurlek C, van Es J, van der Burgh PH, Galjee MA, van Birgelen C (2007) Full pattern of transient apical ballooning of the left ventricle triggered by minor myocardial infarction. Neth Heart J 15:310–311PubMed

55.

Singh V, Mayer T, Salanitri J, Salinger MH (2007) Cardiac MRI documented left ventricular thrombus complicating acute Takotsubo syndrome: an uncommon dilemma. Int J Cardiovasc Imaging 23:591–593CrossRefPubMed

56.

Syed IS, Prasad A, Oh JK et al (2008) Apical ballooning syndrome or aborted acute myocardial infarction? Insights from cardiovascular magnetic resonance imaging. Int J Cardiovasc Imaging 24:875–882CrossRefPubMed

57.

Patrignani A, Di Cesare E, Cicogna S (2009) Echocardiography and cardiovascular magnetic resonance diagnostic role in Takotsubo cardiomyopathy. Int J Cardiovasc Imaging 25:109–112CrossRefPubMed

Title: Tissue characterization in Takotsubo cardiomyopathy; a valuable approach?
Author: E. E. van der Wall
Publication date: 01-02-2010
Publisher: Springer Netherlands
Published in: The International Journal of Cardiovascular Imaging / Issue 2/2010
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI: https://doi.org/10.1007/s10554-009-9534-2

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Tissue characterization in Takotsubo cardiomyopathy; a valuable approach?

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2010

Predictors of response to cardiac resynchronization therapy: the holy grail of electrophysiology

Recent advances in cardiac resynchronization therapy: echocardiographic modalities, patient selection, optimization, non-responders—all you need to know for more efficient CRT

Predictors of ventricular arrhythmias in patients with mitral valve prolapse

Use of cardiac magnetic resonance imaging in the diagnosis of Takotsubo cardiomyopathy: another imaging feature added

Relation of plaque size to compositions as determined by an in vivo volumetric intravascular ultrasound radiofrequency analysis

Cardiovascular dynamics in ischemic cardiomyopathy during exercise

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page